Nitric Oxide: Clinical Trials

4 trials for Nitric Oxide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow Nitric Oxide: new trials by email Literature Review of Nitric Oxide trials Research Report on Nitric Oxide

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled NO in Surgical Patients With Recent COVID-19 Infection
Nitric Oxide Gas - Nitric Oxide, COVID-19
Phase 2CompletedXijing Hospital6602023-02-172024-05-10
Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
Nitric Oxide, Standard CPB - Coronary Artery Disease, Coronary Artery Bypass
Phase 1 / Phase 2CompletedTomsk National Research Medical Center of the Russian Academy of Sciences602015-05-152026-10-21
Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting
Red blood Cells auto-transfusion, Inhaled Nitric Oxide (iNO) administration - Blood Transfusion, Endothelial Physiopathology
Phase 2CompletedMassachusetts General Hospital142012-03-012017-05-22
Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers
L-NMMA and Sodium Nitrite - Nitric Oxide, Endothelium-Derived Relaxing Factor
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)422002-10-012008-03-04

Narrower conditions

Aneurysm (1)  ·  COVID-19 (1)  ·  Coronary Artery Disease (1)  ·  Hypertension, Pulmonary (1)  ·  Motor Activity (1)  ·  Myocardial Reperfusion Injury (1)  ·  Postoperative Complications (1)  ·  Reperfusion Injury (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Behavior (1)  ·  Cardiomyopathies (1)  ·  Coronary Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Heart Diseases (1)  ·  Hypertension (1)

Interventions

Cardiopulmonary Bypass (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Inosine (1)  ·  Nitric Oxide (1)  ·  Organization and Administration (1)  ·  Sodium Nitrite (1)  ·  omega-N-Methylarginine (1)

Sponsors

Massachusetts General Hospital (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Tomsk National Research Medical Center of the Russian Academy of Sciences (1)  ·  Xijing Hospital (1)

Countries

United States (2)  ·  China (1)

Top investigators

Chong Lei, MD&phD (1)  ·  Sergey V Popov, MD (1)  ·  Warren Zapol, MD (1)

Results publications

PMID 25162920, PMID 38485487